Stay updated on RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial
Sign up to get notified when there's something new on the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page.

Latest updates to the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page
- CheckyesterdayChange DetectedAn NIH-wide notice appears above the navigation, linking to updates and FAQs about a terminology change from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check8 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check15 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1, while the study record remains inaccessible with a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the expected study details with an access restriction message. This indicates the record is temporarily unavailable to viewers.SummaryDifference19%

- Check57 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a small internal update to the page without altering the study content.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a software update to the page without altering trial details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page.